p. 1−9
2008-2363
Vol.17/No.100
0.05). Rate of recurrence was 42.1% in HER2 positivecases and 25.6% in HER2negative. Rate of recurrence in both HER2 positive and HER2 negative groups showed no statistically significant difference (p=0.16). Conclusion: There is no significant relation between breast cancer recurrence and over expression of HER2.]]>
p. 10−15
2008-2363
Vol.17/No.100
p. 16−26
2008-2363
Vol.17/No.100